As an example, in considering specific molecular features, DUSP22-rearranged ALCL has been shown to have excellent prognosis, similar to ALK-positive ALCL, possibly rendering ASCT unnecessary, although this will have to be confirmed in larger series [79]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.